Loading…
Loading…
KBLB does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for KBLB and 80,000+ other tickers.
See exactly how KBLB's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for KBLB and 80,000+ other tickers.
Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. The company’s products are used in performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants…
Kraig Labs (OTCQB: KBLB) set another spider silk production record, over 30% more than its previous record levels, even during the difficult rainy season
Kraig Labs (OTCQB: KBLB) CEO published a thought leadership scientific opinion editorial in Biocompare, serving the life sciences and biotech research comm
Kraig Labs (OTCQB: KBLB) CEO and Founder featured in an in-depth interview published by Just Style, a leading global apparel and textile industry trade pub
Kraig Labs (OTCQB: KBLB) CEO and Founder is featured in Authority Magazine's "Meet the Disruptors" series, a widely read publication on the Medium platform
Kraig Labs (OTCQB: KBLB) CEO featured in an extensive interview with Pulse 2.0, where he discussed the Company's technological leadership, commercial produ